Singapore markets closed

TG Therapeutics, Inc. (NKB2.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
12.98+0.21 (+1.66%)
As of 08:02AM CEST. Market open.
Currency in EUR
Earnings estimateCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
No. of analysts7788
Avg. Estimate-0.56-0.56-2.4-2.29
Low estimate-0.61-0.76-2.64-3.11
High estimate-0.48-0.25-1.99-0.97
Year ago EPS-0.73-0.71-2.42-2.4
Revenue estimateCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
No. of analysts7788
Avg. Estimate2.97M9.72M15.2M85.76M
Low estimate2.64M4.1M9M61.53M
High estimate3.54M36.14M44M178.5M
Year ago sales38k38k152k15.2M
Sales growth (year/est)7,715.80%25,478.90%9,900.00%464.20%
Earnings history30/09/202031/12/202031/03/202130/06/2021
Est. EPS-0.41-0.58-0.49-0.5
Actual EPS-0.73-0.71-0.69-0.59
Difference-0.32-0.13-0.2-0.09
Surprise %-78.00%-22.40%-40.80%-18.00%
EPS trendCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
Current estimate-0.56-0.56-2.4-2.29
7 days ago-0.56-0.56-2.4-2.29
30 days ago-0.56-0.56-2.4-2.29
60 days ago-0.49-0.49-2.31-1.44
90 days ago-0.49-0.49-2.31-1.45
EPS revisionsCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesNKB2.FIndustrySector(s)S&P 500
Current qtr.23.30%N/AN/AN/A
Next qtr.21.10%N/AN/AN/A
Current year0.80%N/AN/AN/A
Next year4.60%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A